Tislelizumab
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Jun Liu
Overview
Tislelizumab is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Tislelizumab clinical trials
Explore related
Medical disclaimer. This page summarizes research about Tislelizumab for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.